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Synergistic engagement of the B cell receptor (BCR)
and Toll-like receptor 9 (TLR9) in response to DNA-
containing antigens underlies the production of many
autoantibodies in systemic autoimmune diseases.
However, the molecular basis of this synergistic en-
gagement is not known. Given that these receptors
are spatially segregated, with the BCR on the cell
surfaceandTLR9 inendocytic vesicles, achievingsyn-
ergy must involve unique mechanisms. We show that
upon antigen binding, the BCR initiates signaling at
the plasmamembrane and continues to signal to acti-
vate MAP kinases as it traffics to autophagosome-like
compartments. The internalized BCR signals through
a phospholipase-D-dependent pathway to recruit
TLR9-containing endosomes to the autophagosome
via the microtubular network. The recruitment of
TLR9 to the autophagosomes was necessary for hy-
peractivation ofMAP kinases. This uniquemechanism
for BCR-induced TLR9 recruitment resulting in B cells
hyperresponses may provide new targets for thera-
peutics for autoimmune diseases.
INTRODUCTION
B cell responses are initiated by the binding of multivalent anti-
gens to the highly diversified, clonally distributed B cell receptors
(BCRs). Antigen-induced clustering of theBCRs triggers a signal-
ing cascade that involves the activation of at least four major
signaling pathways that include phospholipase C (PLC), the
Rho family of GTPases, Ras, and phosphatidylinositol-3-kinase
(PI3K) (Campbell, 1999; Kurosaki, 1999). Combinations of these
signaling pathways lead to the activation of MAP kinases and
transcription of a variety of genes associated with B cell activa-
tion (Dal Porto et al., 2004; Schulze-Luehrmann and Ghosh,
2006). In addition, the BCR, under the influence of signaling cas-
cades, efficiently transports antigens to a MHC-class II-contain-
ing, multivesicular, intracellular compartment in which the anti-
gens are proteolytically cleaved and the resulting peptides are
assembled with MHC class II molecules into complexes for rec-
ognition by helper T cells (Lanzavecchia, 1990). Recent studiesprovided evidence that the correct targeting of the BCR to class
II-containing intracellular compartments was dependent on the
activation of phospholipase D (PLD) (Snyder and Pierce, 2006),
a lipase implicated in the intracellular trafficking of a variety of
surface receptors (Melendez and Allen, 2002; Jenkins and Froh-
man, 2005). Antigen binding to the BCR also appears to result in
the clustering or fusion of intracellular vesicles resulting in large
Lysosomal associated membrane protein-1 (LAMP-1)-positive,
MHC-class-II-rich compartments into which the BCR traffics, al-
though the molecular basis of this subcellular reorganization is
not known (Lankar et al., 2002; Siemasko and Clark, 2001).
Lastly, it was shown recently that in antigen-presenting cells,
MHC-class-II-containing intracellular compartments continu-
ously fuse with the autophagosomes, providing means for pre-
sentation of cytosolic proteins on MHC class II molecules
(Schmid et al., 2007).
It has becoming increasingly clear that signaling through the
BCR is regulated or fine-tuned by an array of signaling receptors
receiving information from the B cells’ environment (Dal Porto
et al., 2004). In particular, receptors of the innate immune sys-
tems have been shown to substantially influence the outcome
of antigen engagement by the BCR and may, in fact, contribute
to the immune dysregulation observed in autoimmune diseases
(Bernasconi et al., 2003). Of particular interest are the Toll-like
receptors (TLRs), which are germline-encoded innate immune
receptors that recognize conservedmolecular patterns of micro-
organisms (Akira et al., 2001). Here, we focus on the interactions
of the BCR with TLR9, which recognizes unmethylated CpG-
DNA motifs present in viral and bacterial DNA. As with the
BCR, TLR9-initiated signaling ultimately results in the activation
of the MAP kinases, p38 and JNK, and the transcription factor,
NF-kB, although through signaling pathways distinct from those
triggered by the BCR (Campbell, 1999; Krieg, 2002; Krieg et al.,
1995; Kurosaki, 1999). Indeed, CpG DNA-induced TLR9 signal-
ing has been shown to synergize with antigen-induced BCR sig-
naling in the phosphorylation of p38 and JNK and in NF-kB acti-
vation (Yi et al., 2003). Moreover, this synergistic response was
also evident whenmeasured by cell proliferation and Ig secretion
(Yi et al., 2003). The synergistic engagement of TLR9 and the
BCR in response to DNA-containing antigens has been impli-
cated in the activation of autoimmune B cells (Leadbetter
et al., 2002; Viglianti et al., 2003). Many of the autoantigens tar-
geted in systemic lupus erythematosus (SLE) contain self-DNA,
histones, RNA, or ribonucleoproteins that are thought to beImmunity 28, 799–809, June 2008 ª2008 Elsevier Inc. 799
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BCR Governs TLR9 Subcellular Locationreleased from apoptotic cells. Moreover, TLR9 has been shown
to play a critical role in regulating DNA-specific autoantibody
production in mouse models of lupus by mechanisms that
involve the simultaneous engagement of TLR9 and the BCR
(Christensen et al., 2005; Christensen et al., 2006). The relevance
of TLR9 signaling in B cells to human diseases is underscored by
the observation that genetic variations in TLR9 are linked to SLE
susceptibility (Tao et al., 2007). Consequently, blocking TLR9
signaling in autoreactive B cells has been suggested as a therapy
for SLE (Lenert, 2006). A role for TLRs in autoantibody response
does not appear to be limited to the DNA-binding TLR9 but also
includes the endosomal RNA-binding TLR, TLR7. RNA-associ-
ated autoantigens activate B cells to produce antibodies in
a BCR-and TLR7-dependent manner (Lau et al., 2005). Recently,
the first direct genetic evidence for a role of TLR7 in autoimmune
diseases was provided inmice by the finding that a duplication of
the gene encoding TLR7 resulted in RNA-specific autoantibody
response (Pisitkun et al., 2006). It was subsequently shown
that a simple 2-fold increase in expression of TLR7alonewas suf-
ficient to accelerate autoimmunity (Deane et al., 2007). Thus, it is
becoming essential to understand the molecular basis of the in-
teraction of BCRs and TLRs in response to DNA- and RNA-con-
taining antigens to understand the molecular basis of autoanti-
body responses. At present, little is known about the cellular or
molecular mechanisms that underlie TLR9- and TLR7-enhanced
signaling of the BCR, and given the spatial segregation of the
BCR on the plasma membrane and both TLR9 and TLR7 in early
endosomal compartments (Ahmad-Nejad et al., 2002), it is not
obvious how hyperresponses to DNA- or RNA-containing
antigens are achieved.
In this study, we explore the effect of ligating the BCR and
TLR9 on both the strength and the spatial distribution of the
resulting BCR- and TLR9-mediated signaling. We provide
evidence that after antigen binding and internalization, the
BCR recruits TLR9 frommultiple small endosomes to large auto-
phagosome-like compartments in a microtubule-dependent
process, in which signaling to p38 phosphorylation occurs.
Thus, the hyperresponse of B cells to DNA-containing antigens
appears to involve a unique mechanism of physical recruitment
of TLR9 to the MHC class II antigen-processing compartments
in which the BCRs deliver antigens.
RESULTS
DNA-Containing Antigens Stimulate Hyper MAP Kinase
and NF-kB Responses in B Cells
To understand the molecular basis of B cells hyperresponses to
DNA-containing antigens, we ascertained the effect of ligating
the BCR and TLR9 either independently or together on the phos-
phorylation of p38 and the degradation of I-kB, inhibitor of tran-
scription factor NF- kB. To do so, we treated mouse splenic B
cells with one of the following: F(ab’)2 anti-mouse IgM (anti-
IgM) alone to crosslink the BCR; CpG DNA alone to stimulate
TLR9; anti-IgM andCpGDNA together to simultaneously engage
the BCR and TLR9; or an anti-IgM-CpG DNA conjugate that
could potentially coligate the BCR and TLR9. Consistent with
earlier published findings (Yi et al., 2003), B cells activated with
both anti-IgM and CpG DNA showed a larger increase in p38
phosphorylation and I-kB degradation as compared to B cells800 Immunity 28, 799–809, June 2008 ª2008 Elsevier Inc.treated with either anti-IgM or CpG DNA alone (Figure S1 avail-
able online). This effect was slightly more pronounced when B
cells were treated with an anti-IgM-CpG DNA conjugate. The en-
hanced responses to the combination of CpG DNA and anti-IgM
and to the anti-IgM-CpG conjugate were dependent on TLR9
and were not observed in B cells from TLR9-deficient mice
(Figure S1). TLR9 signaling to CpG is blocked by chloroquine
and bafilomycin as is the enhanced signaling observed to anti-
IgM plus CpG and to anti-IgM-CpG DNA (Figure S1). We also
determined the effect of BCR and TLR9 coligation on the expres-
sion of phospho-p38 in cells by confocal microscopy, as
described in the Experimental Procedures. A larger number of
B cells showed p38 phosphorylation when activated by both
anti-IgM and CpG DNA or with the anti-IgM-CpG DNA conjugate
as compared to either anti-IgM or CpG DNA alone (Figure 1A).
Figure 1. BCR and TLR9 Costimulation Reduces the Threshold for
p38Phosphorylation and IncreasesCD40 and a6-Integrin Expression
(A) The percentage of mouse splenic B cells staining for p-p38- Alexa 488 with
time is shown for B cells fromwild-typemice after treatment with the following:
CpGDNAalone (open squares); 3mManti-IgMalone (closed squares); 10mg/ml
anti-IgM plus CpG DNA (closed circles); and 10 mg/ml anti-IgM-CpG DNA
conjugate (open circles). Approximately 250 cells were examined by confocal
microscopy for each condition in three independent experiments as described
in the Experimental Procedures. Error bars represent standard deviation.
(B) Same as in (A), except B cells from MyD88-deficient mice were used.
(C) Mouse splenic B cells were either untreated or incubated with the following:
10 mg/ml anti-IgM alone; 3 mMstimulatory CpG DNA alone; both 10 mg/ml anti-
IgM and 3 mM CpG DNA; or 10 mg/ml anti-IgM-CpG DNA conjugate for 48 hr.
Cells were stained for B220 and CD40 or a6-integrin or CD54 with appropri-
ately fluorescent antibodies specific for each. Shown are the CD40, a6-
integrin, and CD54 staining in the B220-positive population.
Immunity
BCR Governs TLR9 Subcellular LocationFigure 2. Subcellular Location of TLR9 Changes upon BCR Crosslinking
(A)MousesplenicBcellswereeitheruntreatedorstimulatedwith the following:3mMCpGDNAalone;10mg/mlanti-IgMalone;10mg/mlanti-IgMplus3mMCpG;or10mg/ml
anti-IgM-CpGconjugate for 60min and strained for TLR9 as described. Themerged confocal fluorescent Alexa 488 and differential interference contrast (DIC) images are
shown. Greater than 500 cells were analyzed for each condition in 20 independent experiments, and representative images are shown. Scale bars represent 5 mm.
(B) The intensity analyses of Alexa 488 anti-TLR9 in representative cells in the direction shown by the white arrows in (A).
(C) The immunoelectron microscopy images of cells stained with HRP-anti-TLR9 for cells treated as in (A). The HRP reaction product DAB, visible as a dark stain,
represents the location of TLR9 as shown by white arrows. Scale bars represent 100 nm.We also observed that the B cells stimulated with either anti-IgM
and CpG DNA or with the anti-IgM-CpG DNA conjugate re-
sponded more rapidly than cells stimulated with CpG DNA and
anti-IgM alone. Neither TLR9-induced p38 phosphorylation nor
TLR9 enhancement of BCR signaling were observed in B cells
from MyD88-deficient mice (Figure 1A). We obtained similar re-
sults when analyzing B cells for JNK phosphorylation (data not
shown). Taken together, these results show that a larger number
of B cells reach a threshold for activation and do so more quickly
when stimulated with a mixture of CpG DNA and antigen or with
a CpGDNA-containing antigen. We also determined the effect of
TLR9 and BCR signaling on later functional responses, measur-
ing the cell surface expression of CD40, CD54, and a6-integrin
48 hr after stimulation. The costimulatory molecule CD40 and
a6-integrin were maximally upregulated in the presence of the
anti-IgM-CpGconjugate (Figure 1C). However, anti-IgM-induced
CD54 expression was selectively downregulated in the presence
of CpG either alone or as part of the anti-IgM-CpG conjugate
(Figure 1C). Taken together, these results indicate that DNA-con-
taining antigens affect B cell responses at several points and sug-
gest that the modulating effects of TLR9 on downstream BCR
signaling events are complex. For the remaining analysis, we
focus on the early signaling events including p38 activation.TLR9 Is Recruited to Autophagosome-like
Compartments upon BCR Crosslinking
To learn where synergistic signaling occurred, we determined
the subcellular distribution of TLR9 in resting and activated
splenic B cells by confocal microscopy. In resting B cells,
TLR9 was present in small intracellular vesicles (Figures 2A
and 2B) that colocalized with early endosome markers, such
as antigen 1 (EEA1) and transferrin receptor (TfR) (Figure 3). In
CpG-DNA-stimulated B cells, TLR9 remained in endosomes
(Figures 2A and 2B). Remarkably, crosslinking the BCR with
anti-IgM alone or in combination with CpG DNA or with the
anti-IgM-CpG DNA conjugate resulted in the relocalization of
TLR9 into a single large intracellular structure (Figures 2A and
2B). TLR9 staining was specific and was not detected in B cells
from TLR9-deficient mice under any stimulation condition
(Figure 4C and data not shown). The relocalization of TLR9
induced by both anti-IgM and anti-IgM-CpG DNA occurred in
a time-dependent fashion that was initiated within 5 min and
complete by 30 min (Figure S2), consistent with the observed
time course of p38 phosphorylation (Figure 1A). Similar results
were obtained in HEL-specific transgenic B cells when activated
with HEL either alone or in combination with CpG, indicating that
the recruitment of TLR9 occurs in response to a bona-fideImmunity 28, 799–809, June 2008 ª2008 Elsevier Inc. 801
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BCR Governs TLR9 Subcellular Locationantigen and is not restricted to signals transduced by crosslink-
ing the BCR by anti-Ig (Figure S3). We also observed that the re-
cruitment of TLR9 was absolutely dependent on BCR crosslink-
ing and was not observed in B cells stimulated with CpG alone
for any length of time up to 8 hr (Figure 4A). However, anti-IgM
treatment of B cells stimulated for 8 hr with CpG resulted in the
recruitment of TLR9 (data not shown), suggesting that relocaliza-
tion of TLR9 in B cells is completely governed by the antigen
engagement of the BCR. Moreover, TLR9 recruitment was not
dependent on TLR9 signaling and was observed after BCR
crosslinking in B cells from MyD88-deficient mice (Figure 4B).
To further characterize the compartments to which TLR9 was
recruited, we analyzed B cells by electron microscopy after
staining with HRP-labeled TLR9-specific antibodies developed
with diaminobenzidine (DAB). In resting B cells and in CpG
DNA-stimulated B cells, TLR9 was present in small endosomal
vesicles 100 nm in size (Figure 2C). In contrast, in B cells stim-
ulated through the BCR, the vast majority of TLR9 was present in
double-membrane-enclosed organelles resembling autophago-
somes ranging from 300–500 nm in size (Figure 2C). Autophago-
somes have been reported to be constitutively formed in human
B cell lines (Schmid et al., 2007); however, in primary B cells,
autophagosomes are not well characterized. In many cell types,
autophagosomes function in the degradation and elimination of
damaged organelles and proteins (Levine, 2005; Levine and
Klionsky, 2004). To determine whether the BCR-induced recruit-
ment of TLR9 to autophagosome is a mechanism to degrade
TLR9, we stimulated B cells with anti-IgM for up to 24 hr and
stained them for TLR9. Even after 24 hr of stimulation through
the BCR, TLR9 remained in the autophagosome-like structures
(Figure S4). Moreover, quantification of the intracellular pool of
TLR9 by immunoblotting showed that TLR9 was not degraded
over time after BCR crosslinking and actually increased some-
what in activated B cells (Figure S4).
We next determined whether the process of autophagy plays
a role in the recruitment of TLR9 to autophagosome-like com-
partments. B cells were stimulated in the presence of class III
PI-3-kinase inhibitors, 3-methyladenine (3-MA), or wortmannin
Figure 3. Colocalization of TLR9 to Early
Endosome Markers in Resting Cells
(A) Mouse splenic B cells were stained with anti-
bodies specific for EEA1 labeled with Alexa 488
or for TLR9 labeled with Alexa 647. Shown are
the confocal images of Alexa 488 and Alexa 647
merged with DIC images.
(B) Mouse splenic B cells were stained with
antibodies specific for transferrin receptor (TfR)
labeled with Alexa 555 or for TLR9 labeled with
Alexa 647. Shown are the confocal images of
Alexa 555 and Alexa 488merged with DIC images.
Approximately 200 cells were analyzed from three
independent experiments, and a representative
image is given.
that inhibit autophagy (Blommaart et al.,
1997; Seglen and Gordon, 1982). In the
presence of 3-MA or wortmannin, TLR9
remained in the small endosomes and
did not localize to the autophagosome-
like compartments (Figure S5). We did not observe any effect
of 3-MA or wortmannin on the BCR internalization at the concen-
trations that blocked TLR9 recruitment (Figure S5 and data not
shown). Thus, blocking autophagy blocked BCR recruitment of
TLR9. The BCR-induced recruitment of TLR9 to the autophago-
some-like compartments appeared selective and did not involve
all endosomes. In anti-IgM-stimulated B cells, EM images
showed many endosomal vesicles that were 50–100 nm in
size and that were not recruited to the autophagosome-like com-
partment (Figure S6). In addition, by confocal microscopy many
TfR-containing endosomes did not colocalize with TLR9 in anti-
IgM-stimulated B cells (Figure S6).
MAP Kinase Phosphorylation Occurs at Distinct
Subcellular Sites after TLR9 versus BCR Crosslinking
To determine the intracellular sites from which the BCR and
TLR9 signaled to MAP kinase activation, we stimulated B cells
with anti-IgM and CpG either alone or together or with the anti-
IgM-CpG DNA conjugate. Cells were stained for either phos-
phorylated p38 (p-p38) (Figure 5) or phosphorylated JNK
(p-JNK) (data not shown) and analyzed by confocal microscopy.
No p-p38 was detected in untreated B cells or B cells treated
with nonstimulatory control CpG DNA (Figure 5). In cells stimu-
lated with anti-IgM, p-p38 appeared primarily in a single large in-
tracellular structure, resembling autophagosome-like compart-
ments to which TLR9 was recruited after BCR crosslinking
(Figure 5). Similarly, in cells treated with a combination of anti-
IgM and CpG DNA or with the anti-IgM-CpG DNA conjugate,
the p-p38 appeared in similar autophagosome-like compart-
ments (Figure 5). In contrast, B cells stimulated with CpG DNA
alone showed punctate p-p38 staining (Figure 5), consistent
with the endosomal location of TLR9 (Figure 2). Similar results
were obtained for p-JNK (data not shown). Similar results were
also obtained for HEL-specific transgenic B cells (Figure S3).
The p-p38 colocalized with the BCR in a time-dependent fashion
beginning at 5 min and continuing through 45 min (data not
shown), consistent with the observed time course of p38 phos-
phorylation (Figure 1). In B cells from TLR9- or MyD88-deficient802 Immunity 28, 799–809, June 2008 ª2008 Elsevier Inc.
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anti-IgM-triggered p38 phosphorylation in autophagosome-like
compartments remained intact (data not shown). Taken to-
gether, these results indicate that the observed enhanced signal-
Figure 4. TLR9 Recruitment Is Dependent on BCR Signaling but
Independent of TLR9 Signaling
(A) Mouse splenic B cells were incubated with 3 mMCpG for 1–8 hr and stained
for TLR9 as described. Shown in the panel are DIC images merged with con-
focal images of Alexa 488.
(B) Wild-type and MyD88-deficient B cells were incubated with 10 mg/ml anti-
IgM for 60 min and stained for TLR9 as described. Shown are the DIC images
merged with confocal images of Alexa 488.
(C) TLR9-deficient B cells were either untreated or incubated with 10 mg/ml
anti-IgM for 60 min and stained for TLR9 as described. Shown are the DIC
images merged with confocal images of Alexa 488. For all panels, 200 cells
were analyzed for each condition in five independent experiments and
representative images are provided.ing of B cells in response to anti-IgM and CpG DNA or anti-IgM-
CpG DNA conjugate occurs from autophagosome-like compart-
ments to which TLR9 is recruited.
Internalized BCR Colocalizes with TLR9 and Signals
for p38 Phosphorylation
To directly determine whether the BCR and TLR9 colocalize after
BCR crosslinking, we imaged B cells after incubation at 37C for
60 min with Cy5-conjugated anti-IgM to label and crosslink the
surface BCR and with Cy3-conjugated CpG DNA to activate
and track TLR9. We observed colocalization of the Cy3-CpG
and Cy5-anti-IgM in large intracellular compartments in the ma-
jority of B cells (Figure 6A). We also observed colocalization of
the Cy3-CpG and labeled BCR in HEL-specific transgenic B cells
in response to HEL (Figure S7). B cells labeled with Cy5-anti-IgM
were fixed and permeabilized 60 min after treatment, and three-
color fluorescent microscopy was used for determining the sub-
cellular location of the Cy5-anti-IgM, TLR9, and p-p38 or the
Cy5-anti-IgM, TLR9, and LAMP-1. The internalized BCR colocal-
ized both with TLR9 and p-p38 (Figure 6B). Moreover, internal-
ized BCR and TLR9 also colocalized with markers for MHC
class II antigen-processing compartments in B cells, LAMP-1
(Figure 6C), and invariant chain, Ii (data not shown). The fluores-
cent intensities of the images in Figures 6A and 6B were quanti-
fied, and the overlap is given (Figure S8). Taken together, these
results indicate that after crosslinking, the BCR is internalized
into LAMP-1- and Ii-positive autophagosome-like compart-
ments to which TLR9 is recruited and in which activation of
MAP kinases occurs.
Recruitment of TLR9 to Autophagosome-like
Compartments Requires BCR Internalization
and Signaling
The requirements for BCR-mediated recruitment of TLR9 were
further delineated. We first examined the need for BCR internal-
ization for the recruitment of TLR9 to autophagosome-like com-
partments. Antigen binding to the BCR initiates at the plasma
membrane a PP2-sensitive, Src-family kinase-dependent sig-
naling cascade that results in the internalization of the BCR via
a clathrin-dependent mechanism and its trafficking to the
MHC-class-II-containing compartments (Clark et al., 2003;
Stoddart et al., 2002). Treatment of B cells with PP2 blocked
the BCR-induced TLR9 recruitment to the autophagosome-like
compartments (Figure S9). Moreover, treatment of B cells with
monodansylcadaverine (MDC) that blocks BCR internalization
but not early signaling asmeasured by induction of protein phos-
phorylation (data not shown) also blocked the BCR-induced
TLR9 recruitment to the autophagosome-like compartments
(Figure S9). These results indicate that the physical internaliza-
tion of BCRs into autophagosome-like compartments is key to
the recruitment of TLR9. Concerning the nature of the BCR signal
required for TLR9 recruitment, recruitment was completely
blocked in the presence of calcium chelator, EGTA (data not
shown). However, treatment of B cells with ionomycin and
PMA to mimic a part of downstream BCR signaling was insuffi-
cient for TLR9 recruitment (Figure S9), indicating signaling for
recruitment is more complex.
It has been shown that proper trafficking of the BCR to MHC-
class-II-containing antigen processing compartments relies onImmunity 28, 799–809, June 2008 ª2008 Elsevier Inc. 803
Immunity
BCR Governs TLR9 Subcellular Locationthe activity of phospholipase D (PLD) (Snyder and Pierce, 2006),
an enzyme that plays a role in endocytosis, vesicular trafficking,
and fusion (Jenkins and Frohman, 2005; Snyder and Pierce,
2006). When PLD activity is blocked, BCRs are internalized after
antigen binding but fail to traffic properly to the class II compart-
ments (Snyder and Pierce, 2006). PLD is activated after antigen
binding to the BCR, resulting in hydrolysis of phosphatidylcho-
line into phosphatidic acid (PA) and free choline (Snyder and
Pierce, 2006). To ascertain whether BCR-mediated TLR9 recruit-
ment to autophagosome-like compartments requires PLD activ-
ity, we treated cells with anti-IgM in the presence of n-butanol,
a PLD inhibitor, or with t-butanol as a control and the subcellular
location of TLR9was determined. Treatment of B cells with 0.3%
(v/v) n-butanol completely blocked BCR-mediated recruitment
of TLR9 to autophagosome-like compartments (Figure 7A). The
effect appeared specific in that n-butanol did not affect induction
of protein phosphorylation or BCR internalization (data not
shown) induced by BCR crosslinking. In controls, t-butanol had
no effect on TLR9 recruitment. PA can also be generated from
diacyl glycerol through the action of DAG kinases (DGK) or can
be converted into DAG by the phosphatidic acid phosphohydro-
lases (PAPs) (Jenkins and Frohman, 2005). To ascertain whether
only PLD-produced PA is required for TLR9 recruitment or
whether DAG-converted PA also plays a role, we stimulated cells
in the presence of the DGK inhibitor R59949. The DGK inhibitor
did not block the BCR-mediated TLR9 recruitment, suggesting
the PLD-produced PA is required (Figure 7A). On the other
hand, treatment of cells with CpG alone in the presence of the
PAP inhibitor propranolol resulted in the recruitment of TLR9 to
autophagosome-like compartments (Figure 7A). Taken together,
Figure 5. Phosphorylation of p38 Occurs in
Distinct Subcellular Compartments after
BCR and TLR9 Stimulation
Mouse splenic B cells were either untreated or
incubated with the following: 3 mM control GpC
DNA; 3 mM stimulatory CpG DNA alone; 10 mg/ml
anti-IgM alone; both 10 mg/ml anti-IgM and 3 mM
CpG DNA; or 10 mg/ml anti-IgM-CpG DNA conju-
gate for 60 min. In each case the cells were fixed,
permeabilized, and stained for p-p38 with rabbit
antibodies specific for p-p38 and then Alexa-
488-labeled goat antibodies specific for rabbit Ig.
Shown are the DIC images merged with confocal
images of Alexa 488. Approximately 250 cells
were analyzed for each condition in six indepen-
dent experiments, and representative images are
provided.
Figure 6. Internalized BCR Colocalizes with
TLR9 in LAMP-1-Positive Compartments
(A) Mouse splenic B cells were stimulated with 3
mM Cy3-labeled CpG and 10 mg/ml Cy5-labeled
anti-IgM for 60 min and analyzed by fluorescent
confocal microscopy. Shown are merged DIC
and confocal images of Cy3-CpG and Cy5-anti-
IgM.
(B) Mouse splenic B cells were incubated with 10
mg/ml Cy5-anti-IgM for 60 min, fixed, permeabi-
lized, and stained as described for TLR9 and
p-p38. Shown are the merged DIC and confocal
images of Cy5-anti-IgM, Alexa 488 for TLR9, and
Alexa 565 for anti-p-p38.
(C) Same as in (B), except cells were stained for
TLR9 and LAMP1 and shown are the merged
DIC and confocal images of Cy5-anti-IgM, Alexa
488 for TLR9, and Alexa 565 for LAMP-1. For
all panels, 200 cells were analyzed for each
condition in four independent experiments and
representative images are provided.804 Immunity 28, 799–809, June 2008 ª2008 Elsevier Inc.
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together with PA regulates the recruitment of TLR9 from endo-
some to autophagosome-like compartments.
TLR9 Moves from Endosome to Autophagosome-like
Compartments with the Microtubular Network
We next explored the cellular mechanism by which TLR9-con-
taining endosomes were moved to the autophagosome-like
compartments. A role of microtubular networks has been well
established in the movement of secretory granules in cytotoxic
T lymphocytes and peptide-loadedMHC-class-II-containing en-
dosomal tubules in dendritic cells (Boes et al., 2002; Stinch-
combe et al., 2006). It was also shown that Syk phosphorylates
a-tubulin upon BCR crosslinking (Peters et al., 1996); however,
the function of phosphorylated a-tubulin is not known. We ob-
served that treatment of B cells with the microtubule-disrupting
agent nocodazole blocked the recruitment of TLR9 to autopha-
gosome-like compartments upon BCR crosslinking (Figure 7B);
however, BCR-mediated signaling and BCR internalization
were not affected (data not shown). To determine whether the
BCR-mediated recruitment of TLR9 to autophagosome-like
compartments is required for the observed modulated signaling,
we determined phosphorylation of p38 in the presence of noco-
dazole. Nocodazole treatment blocked by 50–75% the increase
in p38 phosphorylation triggered by treatment with anti-IgM plus
CpG or the anti-IgM-CpG conjugate, indicating that TLR9
recruitment was necessary for enhanced signaling (Figure 7C).
Nocodazole treatment, however, also reduced anti-IgM-induced
p38 phosphorylation and increased somewhat the CpG-induced
p38 phosphorylation (Figure 7C). Taken together, these results
indicated that BCR-induced recruitment of TLR9 to the autopha-
gosome-like compartments is important for enhanced signaling
to p38 in response to DNA-containing antigens. However,
disabling the microtubular network also influenced the quality
of downstream signaling pathways emanating from both the
BCR and TLR9.
DISCUSSION
Multiple studies have suggested the importance of synergistic
engagement of TLR9 and the BCR in hyper B cells responses in
autoimmunity (Leadbetter et al., 2002; Viglianti et al., 2003). A
growing number of studies indicate that TLRs play important
roles in defining B cell responses to both T dependent and T in-
dependent antigens and that bothDNA- andRNA-containing an-
tigen complexes stimulate autoantibodyproduction in aBCRand
TLR9- or TLR7-dependent manner (Leadbetter et al., 2002; Vig-
lianti et al., 2003). However, the mechanism by which these
spatially segregated receptors interact in response to DNA- and
RNA-containing antigens has not been previously addressed.
Earlier reports suggested that theBCRmight function as a shuttle
for the delivery of DNA and RNA to the TLR9- and TLR7-contain-
ing compartments; however, no evidence was provided for such
a mechanism (Leadbetter et al., 2002; Viglianti et al., 2003).
The results presented here provide evidence for a unique
pathway by which B cells regulate responses to DNA-containing
Figure 7. BCR-Induced TLR9 Recruitment
to Autophagosome-like Compartments
Requires PLD Activity and the Microtubular
Network
(A) Mouse splenic B cells were incubated with the
following: 10 mg/ml anti-IgM in the presence of
0.3% (v/v) n-Butanol; 0.3% (v/v) t-Butanol; or
10 mM DGK inhibitor R59949. Alternatively, cells
were incubated with 3 mM CpG in the presence
of 100 mM PAP inhibitor Propranolol for 60 min.
Cells were stained for TLR9 as described. Merged
confocal and DIC images of Alexa 488 are shown.
(B) Cells were incubated with 10 mg/ml anti-IgM;
3 mM CpG DNA alone; both 10 mg/ml anti-IgM and
3 mM CpG DNA; or 10 mg/ml anti-IgM-CpG DNA
conjugate in the presence of nocodazole (100 mg/
ml) for 60 min. Cells were stained for TLR9 as de-
scribed. Shown are confocal and DIC images of
Alexa 488. Approximately 200 cells were analyzed
for each condition in five independent experiments
and representative images are provided.
(C) Mouse splenic B cells were either untreated or
incubated with the following: 10 mg/ml anti-IgM
alone; 3 mM stimulatory CpG DNA alone; both
10 mg/ml anti-IgM and 3 mMCpGDNA; or 10 mg/ml
anti-IgM-CpG DNA conjugate either in the ab-
sence or presence of nocodazole for 60 min. We
prepared and analyzed cytoplasmic extracts by
SDS-PAGE and immunoblotting, probing with
p-p38-specific antibodies. Blots were stripped
and reprobed with tubulin-specific antibodies. The
intensities of the p-p38 and tubulin bands were
quantified with ImageJ software and expressed
as a ratio of p-p38 to tubulin for each condition.Immunity 28, 799–809, June 2008 ª2008 Elsevier Inc. 805
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In our study, we show that in resting B cells, TLR9 is localized in
punctate, small endosomal compartments and signals in these
compartments to MAP kinase activation after stimulation by
CpG alone. However, the location of TLR9 is dramatically altered
in cells in which the BCR is crosslinked by antigen. After BCR
crosslinking, the BCR initiates signaling at the plasmamembrane
and then traffics to LAMP-1-positive autophagosome-like com-
partments in which the BCR signals to MAP kinase activation.
TLR9 is recruited to these compartments in which it colocalizes
with the BCR. The recruitment of TLR9 to the autophagosome is
required for enhanced signaling because the hyperactivation of
MAP kinases to the anti-IgM and CpG DNA was not observed
when TLR9 recruitment was blocked by the tubulin-depolymeriz-
ing agent, nocodazole.
A number of earlier studies indicated that TLR9 is located in
late endosomes or lysosomes in which it signals upon CpG
DNA stimulation, consistent with the endosomal location of
TLR9 in primary splenic B cells presented here (Ahmad-Nejad
et al., 2002; Tabeta et al., 2006). However, a more detailed anal-
ysis provided evidence that TLR9 was concentrated in the endo-
plasmic reticulum (ER) of dendritic cells, macrophages, and a B
cell line and that upon stimulation with CpGDNA, TLR9 redistrib-
uted from the ER to CpG-DNA-containing endosomes (Latz
et al., 2004; Leifer et al., 2004). The mechanism underlying this
redistribution of TLR9 is not known; however, a relationship
between the ER and endosomes in TLR9 signaling was also sug-
gested by the finding that a mutation in the gene encoding the
12-membrane spanning protein, UNC93B, a highly conserved
resident ER protein, resulted in a complete deficiency in signal-
ing via TLR3, TLR7, and TLR9 but did not alter their subplasma-
lemmal vesicular compartmentalization (Tabeta et al., 2006). The
UNC93B mutation also resulted in deficiencies in antigen cross-
presentation, a process that involves both autophagy and endo-
cytic trafficking. Moreover, recently it has been shown that TLR3,
TLR7, and TLR9 physically interact with UNC93B, and this inter-
action is mediated through the transmembrane domain of at
least TLR3 and TLR9 (Brinkmann et al., 2007). Taken together,
these findings suggest a link between the ER and endosomal
TLR9 signaling that will be of interest to explore.
The results provided here indicate that the antigen-bound
BCR and TLR9 colocalize and signal from autophagosome-like
compartments. Recently evidence was provided that autopha-
gosomes play an important role in intracellular TLR signaling.
In pDCs, TLR7 gains access to single-strand RNA viruses and
viral-replication intermediates through autophagy (Lee et al.,
2007). In B cells, autophagosomes have been less well charac-
terized; however, recent results showed that a relationship exists
between the class-II-loading compartments and autophago-
somes, and such a relationship results in the delivery of cytosolic
antigens to class-II-loading compartments (Schmid et al., 2007).
It remains to be determined whether similar mechanisms are at
play for the relocalization of TLR9 to class-II-loading compart-
ments in which BCR traffics DNA-containing antigens. It will
also be of interest to determinewhether BCR-induced relocaliza-
tion of TLR9 to autophagosome-like compartments is limited to
TLR9 or is also observed with other intracellular TLRs. We pro-
vide evidence here that the recruitment of TLR9 was selective
to the extent that TfR-positive endosomes were not recruited806 Immunity 28, 799–809, June 2008 ª2008 Elsevier Inc.along with TLR9-positive endosomes. However, the regulation
of the location of the TLR3 and TLR7 is of interest. Indeed,
TLR3 that recognizes dsRNA is constitutively present in multive-
sicular bodies of a B cell line (Matsumoto et al., 2003).
The studies presented here support a model for B cell hyper-
responses to DNA-containing antigen in which the antigen-en-
gaged, internalized BCR signals to recruit TLR9 to autophago-
some-like compartments to allow TLR9 to survey the antigen
for its DNA ligand. If the ligand is present in the BCR-bound
antigen, TLR9 is engaged and activated. How does this process
result in autoantibody production? The enhanced signaling from
autophagosomes through the BCR and TLR9 may contribute to
autoantibody production by reducing the threshold for B cell ac-
tivation. Alternatively, the subcellular location of TLR9 could in-
fluence its specificity for ODNs as suggested by the observation
that a chimeric TLR9 receptor that localized to the cell surface
rather than endosomes responded to both self- and nonself-
DNA (Barton et al., 2006). In addition, in plasmacytoid dendritic
cells, the subcellular location to which CpG is delivered dictates
the outcome of MyD88-IRF7 signaling (Honda et al., 2005). Addi-
tional studies indicated that crosslinking the BCR that we now
know recruits TLR9 to autophagosomes resulted in the B cells’
ability to respond to a broader array of CpG-containing ODNs,
includingmethylated DNA, which occurs in self-DNA (Goeckeritz
et al., 1999). Thus, it is possible that TLR9 recruitment to the
autophagosomes by the BCR may have a substantial effect
on the ability of the BCR to discriminate self and nonself-
DNA-containing antigens.
Another important aspect of the recruitment of TLR9 vesicles
to BCR-containing autophagosome-like compartments is the
possible need to regulate recruitment. Presumably, the TLR9 is
induced to locate to the class-II-loading compartments rather
than being constitutively present in that compartment to allow
regulation of the TLR amplification of BCR signaling. It will be
of interest to determine whether BCR coreceptors such as the in-
hibitory FcgRIIB, which has emerged as a key factor in autoim-
munity (Schmidt and Gessner, 2005), regulates TLR recruitment
by the BCR. In addition, because multivesicular bodies in B cells
are the subcellular sites in which the MHC class II molecules are
assembled with peptides derived from the BCR-bound antigen,
recruitment of TLR9 into the class-II-loading compartments
along with the antigen might influence the ability of the BCR to
present DNA-containing antigens to helper T cells.
Lastly, an important aspect of the studies presented here is the
evidence that the BCR continues to signal after its internalization
to class-II-loading compartments and, moreover, that the intra-
cellular signaling is required for TLR9 recruitment. A number of
cell-surface receptors have been shown to continue to signal
as they are internalized, and that intracellular signaling was es-
sential for the function of the receptor (Grimes et al., 1996; Vieira
et al., 1996;Wang et al., 2002). To date, the intracellular signaling
of the immune receptors has not been investigated in detail and
a few studies suggested that signaling was extinguished once
the receptor was internalized. Here, we provide evidence that
the BCR-initiated phosphorylation of p38 continues as the
BCR is internalized into the cells, first into small endosomal ves-
icles then into class-II-loading compartments. Thus, the spatial
segregation of the BCR’s activation of p38may play an important
role in facilitating interaction with TLR9. It is also possible that the
Immunity
BCR Governs TLR9 Subcellular Locationintracellular location of late BCR signaling may play additional
roles in regulating B cell activation.
In conclusion, we describe a unique mechanism underlying
a fundamental property of the immune system, namely the syn-
ergistic interactions between the signaling receptors of adaptive
and innate immunity. We demonstrate that in B lymphocytes, en-
hanced signaling of the BCR and TLR9 is achieved by the recruit-
ment of TLR9 from endosomes to large autophagosome-like
compartments in which the BCR delivers antigens. The recruit-
ment of TLR9 to BCR-containing compartments presumably
allows TLR9 to interrogate the BCR-bound antigen for the pres-
ence of its DNA ligand. Indeed, recruitment of TLR9 to autopha-
gosome-like compartments is required for the hyperresponses
of B cells to DNA-containing antigens. Taken together, our
data advance our understanding of interplay of adaptive and in-
nate immune response, showing that the adaptive system’s BCR
controls the location of innate system receptor TLR9.
EXPERIMENTAL PROCEDURES
Reagents, Cells, and Mice
Single-strandedphosphorothioateCpG-DNA (50-TCCATgACgTTCCTgACgTT-
30), control GpC-DNA (50-TCCATgAgCTTCCTgAgCTT-30), and 50-amino modi-
fied oligos were purchased fromOperon Biotechnologies, Huntsville, AL, USA.
Cy3-labeled CpG DNA was purchased from Tri-Link Biotechnologies, San
Diego, CA, USA. PP2, bafilomycin, propranolol and R59949 were purchased
from Calbiochem, San Diego, CA, USA. Monodansylcadaverine and chloro-
quinewere purchased fromSigma-Aldrich, St. Louis,MO,USA. F(ab’)2 goat an-
tibodies specific for mouse anti-IgM (anti-IgM) and HRP-conjugated goat anti-
bodies specific for mouse IgG and rabbit IgG were purchased from Jackson
Immuno Research Laboratories, West Grove, PA, USA. Antibodies specific
for p-JNK were purchased from Cell Signaling Technology, Danvers, MA,
USA. Phospho-p38-specific antibodies were purchased from R&D Systems,
Minneapolis, MN, USA. I-kB- and LAMP1- specific antibodies were from Santa
CruzBiotechnologies,SantaCruz,CA,USA.Alexa-488-labeledgoatantibodies
specific formouse Igand rabbit Ig andAlexa-565-labeledantibodies specific for
rat Ig and rabbit Ig and a Zenon antibody-labeling kit were purchased from In-
vitrogen, Carlsbad, CA, USA. The TLR9-specific mAb, clone-26C593.2, was
obtained from Imgenex, San Diego, CA, USA. The TLR9-specific mAb, clone-
26C593.2, was conjugated to HRP with a Zenon antibody-labeling kit. Another
TLR9-specific mAb, clone 5G5 from Hycult Biotechnology (Uden, The Nether-
lands), was also used and similar results were obtained (data not shown).
Breeding pairs for TLR9- and MyD88-deficient mice were provided by Dr. Shi-
zuo Akira, Osaka University, Osaka, Japan. Mice were bred and maintained in
our animal facility. C57/BL6 mice were purchased from Jackson Laboratory,
Bar Harbor,ME, USA. HEL transgenicmiceMD4were purchased fromTaconic
farms (Hudson, NY, USA). B cells were purified from spleens of mice as previ-
ously described (Chaturvedi et al., 2002). All animals were housed and studied
under approved institutional guidelines.
Synthesis of Anti-IgM-CpG Conjugate
We incubated anti-IgM with a 20-fold molar excess of succinimidyl-6-hydrazi-
nonicotinate acetone hydrazone, SANH, Solulink Biotechnologies, San Diego,
CA, USA, at 25C for 3 hr to modify the amino side chains of lysine residues
by incorporating hydrazine groups. Residual SANH was removed by chroma-
tography on a G-25 column (Amersham Pharmacia Biotech, Piscataway, NJ,
USA). 50-amino-modifiedCpGDNAor control DNAwas incubatedwith succini-
midyl-4-formylbenzoate, SFB, Solulink Biotechnologies, at 25C for 3 hr for in-
corporation of a 4 formyl benzamide moiety. Residual SFB was removed by
chromatography on a G-25 column. The resulting 50-modified DNA was mixed
with themodified anti-IgM at a 5:1molar ratio and incubated overnight at 25C.
The anti-IgM-CpG conjugate was purified by size-exclusion chromatography.
The anti-IgM-CpG conjugate samples were determined to be lipopolysaccha-
ride free by Limulus amebocyte lysate assay (BioWhittaker, Walkersville, MD,USA). Immunoblotting was performed as previously described (Snyder and
Pierce, 2006).
Confocal Microscopy
Purified splenic B cells attached to poly-lysine coated chamber slides (Bio-Coat,
Horsham, PA, USA), were treated with the indicated stimuli at 37C for the indi-
cated times,fixedwith3.7%paraformaldehyde for 20minat25C,permeabilized
with 0.2%TX-100 inPBS-BSA,blockedwith50mg/mlof purifiednormal goat IgG
for 20minat25C,and incubatedwithantibodiesspecific forphosphorylatedp38
or TLR9 for 2 hr at 25C. The Alexa-fluor-conjugated goat antibodies specific for
rabbit Igorgoatantibodies formouse Igwereadded in thedark for45minat25C.
The coverslips were mounted in Prolong Antifade (Invitrogen) and examined by
fluorescencemicroscopy with Zeiss 510Meta confocal microscope (Carl Zeiss).
Approximately 250 cells were analyzed for each experimental condition. Cells
were scoredpositivebyan investigatorwhowasblinded to theexperimental pro-
tocol when the fluorescence appeared to be several fold above background.
To follow the uptake of anti-IgM and CpG, we suspended mouse B cells in
RPMI plus 0.5% BSA and allowed them to attach to poly-L-lysine-coated cov-
erslip chambers (LAB-TEK, Nalge Nunc International, Naperville, IL, USA).
Cells were incubated with 3 uM Cy3-labeled CpG DNA and Cy5-labeled
anti-IgM in RPMI plus 2% serum at 37C for various times and visualized by
time-lapse fluorescence microscopy with a Zeiss 510 Meta confocal micro-
scope equipped with a heated stage, a heated air circulation system, and an
objective heater (Carl Zeiss). A Zeiss Plan-Apochromat 633 oil-immersion
objective was used for image acquisition.
Electron Microscopy
Mouse splenic B cells were activated in suspension culture as indicated at 37C
for 60min, rinsedwithPBS, and fixed in periodate-lysine-paraformaldehyde fix-
ative containing 0.35% glutaraldehyde for 1 hr at 25C. Cells were washed and
permeabilized with PBS containing 0.02% saponin for 5 min at 25C and incu-
bated with HRP-labeled TLR9-specific mAb (clone-26C593.2) in PBS contain-
ing 0.02% saponin for 2 hr. Cells were washed in PBS, fixed in 0.1 M sodium
phosphate containing 1.5% glutaraldehyde and 5% sucrose (pH 7.4) for 1 hr
at 25C, washed with 50 mM Tris-HCl (pH 7.4) plus 7.5% sucrose, and devel-
oped with metal-enhanced DAB substrate (Pierce, Rockford, IL, USA). Cells
were rinsed with 50 mM Tris-HCl (pH 7.4), plus 7.5% sucrose, and prefixed in
4%paraformaldehyde plus 2.5%glutaraldehyde in 100mM sodiumphosphate
buffer (pH7.4).Cellswerepostfixed in0.8%potassium ferrocyanidewith the1%
osmium tetroxide and washed in phosphate buffer and water. Cells were dehy-
drated in a graded ethanol series and embedded in Spurr’s resin. Thin sections
were cut with an MT-7000 ultramicrotome (RMC, Tucson, AZ, USA). Samples
were examined on a Hitachi H7500 TEM at 80 kV, and images were captured
with a CCD camera (Advanced Microscopy Technologies, Danvers, MA, USA).
SUPPLEMENTAL DATA
Nine figures are available at http://www.immunity.com/cgi/content/full/28/6/
799/DC1/.
ACKNOWLEDGMENTS
We thank S. Akira, Osaka University, Japan for TLR9-and MyD88-deficient
mice and K. Takabayashi and E. Raz, UCSD, San Diego, USA, for suggestions
in anti-IgM-CpG conjugate synthesis. This research was supported by the
Intramural Research Program of the NIH, National Institute of Allergy and
Infectious Diseases.
Received: December 3, 2007
Revised: February 27, 2008
Accepted: March 25, 2008
Published online: May 29, 2008
REFERENCES
Ahmad-Nejad, P., Hacker, H., Rutz, M., Bauer, S., Vabulas, R.M., andWagner,
H. (2002). Bacterial CpG-DNA and lipopolysaccharides activate Toll-like
receptors at distinct cellular compartments. Eur. J. Immunol. 32, 1958–1968.Immunity 28, 799–809, June 2008 ª2008 Elsevier Inc. 807
Immunity
BCR Governs TLR9 Subcellular LocationAkira, S., Takeda, K., and Kaisho, T. (2001). Toll-like receptors: Critical proteins
linking innate and acquired immunity. Nat. Immunol. 2, 675–680.
Barton, G.M., Kagan, J.C., and Medzhitov, R. (2006). Intracellular localization
of Toll-like receptor 9 prevents recognition of self DNA but facilitates access to
viral DNA. Nat. Immunol. 7, 49–56.
Bernasconi, N.L., Onai, N., and Lanzavecchia, A. (2003). A role for Toll-like
receptors in acquired immunity: Up-regulation of TLR9 by BCR triggering in
naive B cells and constitutive expression in memory B cells. Blood 101,
4500–4504.
Blommaart, E.F., Krause, U., Schellens, J.P., Vreeling-Sindelarova, H., and
Meijer, A.J. (1997). The phosphatidylinositol 3-kinase inhibitors wortmannin
and LY294002 inhibit autophagy in isolated rat hepatocytes. Eur. J. Biochem.
243, 240–246.
Boes, M., Cerny, J., Massol, R., Op den Brouw, M., Kirchhausen, T., Chen, J.,
and Ploegh, H.L. (2002). T-cell engagement of dendritic cells rapidly rear-
ranges MHC class II transport. Nature 418, 983–988.
Brinkmann, M.M., Spooner, E., Hoebe, K., Beutler, B., Ploegh, H.L., and Kim,
Y.M. (2007). The interaction between the ER membrane protein UNC93B and
TLR3, 7, and 9 is crucial for TLR signaling. J. Cell Biol. 177, 265–275.
Campbell, K.S. (1999). Signal transduction from the B cell antigen-receptor.
Curr. Opin. Immunol. 11, 256–264.
Chaturvedi, A., Siddiqui, Z., Bayiroglu, F., and Rao, K.V. (2002). A GPI-linked
isoform of the IgD receptor regulates resting B cell activation. Nat. Immunol.
3, 951–957.
Christensen, S.R., Kashgarian, M., Alexopoulou, L., Flavell, R.A., Akira, S., and
Shlomchik, M.J. (2005). Toll-like receptor 9 controls anti-DNA autoantibody
production in murine lupus. J. Exp. Med. 202, 321–331.
Christensen, S.R., Shupe, J., Nickerson, K., Kashgarian, M., Flavell, R.A., and
Shlomchik, M.J. (2006). Toll-like receptor 7 and TLR9 dictate autoantibody
specificity and have opposing inflammatory and regulatory roles in a murine
model of lupus. Immunity 25, 417–428.
Clark, M.R., Massenburg, D., Zhang, M., and Siemasko, K. (2003). Molecular
mechanisms of B cell antigen receptor trafficking. Ann. N Y Acad. Sci. 987,
26–37.
Dal Porto, J.M., Gauld, S.B., Merrell, K.T., Mills, D., Pugh-Bernard, A.E., and
Cambier, J. (2004). B cell antigen receptor signaling 101. Mol. Immunol. 41,
599–613.
Deane, J.A., Pisitkun, P., Barrett, R.S., Feigenbaum, L., Town, T., Ward, J.M.,
Flavell, R.A., and Bolland, S. (2007). Control of Toll-like receptor 7 expression
is essential to restrict autoimmunity and dendritic cell proliferation. Immunity
27, 801–810.
Goeckeritz, B.E., Flora, M., Witherspoon, K., Vos, Q., Lees, A., Dennis, G.J.,
Pisetsky, D.S., Klinman, D.M., Snapper, C.M., and Mond, J.J. (1999). Multiva-
lent cross-linking of membrane Ig sensitizes murine B cells to a broader spec-
trum of CpG-containing oligodeoxynucleotide motifs, including their methyl-
ated counterparts, for stimulation of proliferation and Ig secretion. Int.
Immunol. 11, 1693–1700.
Grimes, M.L., Zhou, J., Beattie, E.C., Yuen, E.C., Hall, D.E., Valletta, J.S.,
Topp, K.S., LaVail, J.H., Bunnett, N.W., and Mobley, W.C. (1996). Endocytosis
of activated TrkA: Evidence that nerve growth factor induces formation of
signaling endosomes. J. Neurosci. 16, 7950–7964.
Honda, K., Ohba, Y., Yanai, H., Negishi, H., Mizutani, T., Takaoka, A., Taya, C.,
and Taniguchi, T. (2005). Spatiotemporal regulation of MyD88-IRF-7 signalling
for robust type-I interferon induction. Nature 434, 1035–1040.
Jenkins, G.M., and Frohman, M.A. (2005). Phospholipase D: A lipid centric
review. Cell. Mol. Life Sci. 62, 2305–2316.
Krieg, A.M. (2002). CpG motifs in bacterial DNA and their immune effects.
Annu. Rev. Immunol. 20, 709–760.
Krieg, A.M., Yi, A.K., Matson, S., Waldschmidt, T.J., Bishop, G.A., Teasdale,
R., Koretzky, G.A., and Klinman, D.M. (1995). CpGmotifs in bacterial DNA trig-
ger direct B-cell activation. Nature 374, 546–549.
Kurosaki, T. (1999). Genetic analysis of B cell antigen receptor signaling. Annu.
Rev. Immunol. 17, 555–592.808 Immunity 28, 799–809, June 2008 ª2008 Elsevier Inc.Lankar, D., Vincent-Schneider, H., Briken, V., Yokozeki, T., Raposo, G., and
Bonnerot, C. (2002). Dynamics of major histocompatibility complex class II
compartments during B cell receptor-mediated cell activation. J. Exp. Med.
195, 461–472.
Lanzavecchia, A. (1990). Receptor-mediated antigen uptake and its effect on
antigen presentation to class II-restricted T lymphocytes. Annu. Rev. Immunol.
8, 773–793.
Latz, E., Schoenemeyer, A., Visintin, A., Fitzgerald, K.A., Monks, B.G., Knetter,
C.F., Lien, E., Nilsen, N.J., Espevik, T., and Golenbock, D.T. (2004). TLR9
signals after translocating from the ER to CpG DNA in the lysosome. Nat.
Immunol. 5, 190–198.
Lau, C.M., Broughton, C., Tabor, A.S., Akira, S., Flavell, R.A., Mamula, M.J.,
Christensen, S.R., Shlomchik, M.J., Viglianti, G.A., Rifkin, I.R., and Marshak-
Rothstein, A. (2005). RNA-associated autoantigens activate B cells by com-
bined B cell antigen receptor/Toll-like receptor 7 engagement. J. Exp. Med.
202, 1171–1177.
Leadbetter, E.A., Rifkin, I.R., Hohlbaum, A.M., Beaudette, B.C., Shlomchik,
M.J., and Marshak-Rothstein, A. (2002). Chromatin-IgG complexes activate
B cells by dual engagement of IgM and Toll-like receptors. Nature 416,
603–607.
Lee, H.K., Lund, J.M., Ramanathan, B., Mizushima, N., and Iwasaki, A. (2007).
Autophagy-dependent viral recognition by plasmacytoid dendritic cells.
Science 315, 1398–1401.
Leifer, C.A., Kennedy, M.N., Mazzoni, A., Lee, C., Kruhlak, M.J., and Segal,
D.M. (2004). TLR9 is localized in the endoplasmic reticulum prior to stimula-
tion. J. Immunol. 173, 1179–1183.
Lenert, P.S. (2006). Targeting Toll-like receptor signaling in plasmacytoid den-
dritic cells and autoreactive B cells as a therapy for lupus. Arthritis Res. Ther. 8,
203.
Levine, B. (2005). Eating oneself and uninvited guests: Autophagy-related
pathways in cellular defense. Cell 120, 159–162.
Levine, B., and Klionsky, D.J. (2004). Development by self-digestion: Molecu-
lar mechanisms and biological functions of autophagy. Dev. Cell 6, 463–477.
Matsumoto, M., Funami, K., Tanabe, M., Oshiumi, H., Shingai, M., Seto, Y.,
Yamamoto, A., and Seya, T. (2003). Subcellular localization of Toll-like recep-
tor 3 in human dendritic cells. J. Immunol. 171, 3154–3162.
Melendez, A.J., and Allen, J.M. (2002). Phospholipase D and immune receptor
signalling. Semin. Immunol. 14, 49–55.
Peters, J.D., Furlong,M.T., Asai, D.J., Harrison,M.L., andGeahlen, R.L. (1996).
Syk, activated by cross-linking the B-cell antigen receptor, localizes to the
cytosol where it interacts with and phosphorylates alpha-tubulin on tyrosine.
J. Biol. Chem. 271, 4755–4762.
Pisitkun, P., Deane, J.A., Difilippantonio, M.J., Tarasenko, T., Satterthwaite,
A.B., and Bolland, S. (2006). Autoreactive B cell responses to RNA-related
antigens due to TLR7 gene duplication. Science 312, 1669–1672.
Schmid, D., Pypaert, M., and Munz, C. (2007). Antigen-loading compartments
for major histocompatibility complex class II molecules continuously receive
input from autophagosomes. Immunity 26, 79–92.
Schmidt, R.E., and Gessner, J.E. (2005). Fc receptors and their interactionwith
complement in autoimmunity. Immunol. Lett. 100, 56–67.
Schulze-Luehrmann, J., and Ghosh, S. (2006). Antigen-receptor signaling to
nuclear factor kappa B. Immunity 25, 701–715.
Seglen, P.O., and Gordon, P.B. (1982). 3-Methyladenine: Specific inhibitor of
autophagic/lysosomal protein degradation in isolated rat hepatocytes. Proc.
Natl. Acad. Sci. USA 79, 1889–1892.
Siemasko, K., and Clark, M.R. (2001). The control and facilitation of MHC class
II antigen processing by the BCR. Curr. Opin. Immunol. 13, 32–36.
Snyder, M.D., and Pierce, S.K. (2006). A mutation in Epstein-Barr virus LMP2A
reveals a role for phospholipase D in B-Cell antigen receptor trafficking. Traffic
7, 993–1006.
Stinchcombe, J.C., Majorovits, E., Bossi, G., Fuller, S., and Griffiths, G.M.
(2006). Centrosome polarization delivers secretory granules to the immunolog-
ical synapse. Nature 443, 462–465.
Immunity
BCR Governs TLR9 Subcellular LocationStoddart, A., Dykstra, M.L., Brown, B.K., Song, W., Pierce, S.K., and Brodsky,
F.M. (2002). Lipid rafts unite signaling cascades with clathrin to regulate BCR
internalization. Immunity 17, 451–462.
Tabeta, K., Hoebe, K., Janssen, E.M., Du, X., Georgel, P., Crozat, K., Mudd, S.,
Mann, N., Sovath, S., Goode, J., et al. (2006). The Unc93b1 mutation 3d
disrupts exogenous antigen presentation and signaling via Toll-like receptors
3, 7 and 9. Nat. Immunol. 7, 156–164.
Tao, K., Fujii, M., Tsukumo, S., Maekawa, Y., Kishihara, K., Kimoto, Y., Horiu-
chi, T., Hisaeda, H., Akira, S., Kagami, S., and Yasutomo, K. (2007). Genetic
variations of Toll-like receptor 9 predispose to systemic lupus erythematosus
in Japanese population. Ann. Rheum. Dis. 66, 905–909.Vieira, A.V., Lamaze, C., and Schmid, S.L. (1996). Control of EGF receptor
signaling by clathrin-mediated endocytosis. Science 274, 2086–2089.
Viglianti, G.A., Lau, C.M., Hanley, T.M., Miko, B.A., Shlomchik, M.J., and
Marshak-Rothstein, A. (2003). Activation of autoreactive B cells by CpG
dsDNA. Immunity 19, 837–847.
Wang, Y., Pennock, S., Chen, X., and Wang, Z. (2002). Endosomal signaling of
epidermal growth factor receptor stimulates signal transduction pathways
leading to cell survival. Mol. Cell. Biol. 22, 7279–7290.
Yi, A.K., Yoon, J.G., and Krieg, A.M. (2003). Convergence of CpG DNA- and
BCR-mediated signals at the c-Jun N-terminal kinase and NF-kappaB activa-
tion pathways: Regulation by mitogen-activated protein kinases. Int. Immunol.
15, 577–591.Immunity 28, 799–809, June 2008 ª2008 Elsevier Inc. 809
